Company intelligence / Profile preview

Relion Conception

San Francisco Bay Area, California, United Statesfr.linkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Conception has demonstrated that its IVG technology can generate viable mouse eggs capable of producing healthy live mice. The company is now focused on translating this success to humans by creating proof-of-concept human eggs and optimizing processes for safety and quality control. No clinical trials in humans have been reported yet.

Therapeutic areas: Rare DiseasesWomen's Health
Modalities: Cell therapyStem cell therapyIn-vitro gametogenesis (IVG) technology
Industry: Biotech

Beyond the preview

Go deeper on Relion Conception.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relion Conception.

Explore the full profile